Further studies in neuroblastoma cells have demonstrated that CANT1 is a target gene of the DREAM protein, a Ca2+-dependent transcriptional repressor, and its activity is essential to the correct ER protein folding and degradation processes [24]. The gene discussed is CANT1; the disease is neuroblastoma.